|
Allos Therapeutics Stage: Growth Date of Investment: 2005 Web Site : http://www.allos.com Stock Symbol : NASDAQ: ALTH |
 |
Allos Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing small molecule drugs for the treatment of cancer. In 2005, Warburg Pincus invested $50 million in Allos to lead a $52 million private placement. Founded in 1994 and publicly traded since 2000, Allos has multiple product candidates in development focusing on oncology, including a Phase III radiation sensitizer for the treatment of brain metastases.
